PortViewPortView
Scilex Holding logo

Scilex Holding (SCLX) Stock Analysis

NASDAQHealthcareDrug Manufacturers - General

$5.47+1.20%
1-year price historyRange $3.69 – $30.00
52-week range$5.47
$2.62$21.34

What Scilex Holding does

Scilex Holding Company is a biopharmaceutical enterprise that specializes in the development and market introduction of non-opioid therapies designed to alleviate both acute and chronic pain. Its primary marketed offering is ZTlido 1.8%, a topical prescription formulation of lidocaine specifically engineered to mitigate neuropathic discomfort associated with post-herpetic neuralgia, a condition characterized by persistent nerve pain following shingles. Beyond this, the company's development pipeline includes SP-102, a viscous gel corticosteroid for epidural administration, currently undergoing Phase III trials for lumbosacral radicular pain. Another candidate, SP-103, is progressing through Phase II trials for managing low back pain. Furthermore, SP-104, a novel, low-dose, delayed-release naltrexone hydrochloride formulation, has successfully concluded Phase I clinical testing for the treatment of fibromyalgia. Its corporate offices are situated in Palo Alto, California. Scilex Holding Company operates as a subsidiary of Sorrento Therapeutics, Inc.

Key metrics

Market cap
$46.40M
P/E (TTM)
-0.14
EPS (TTM)
$-38.95
Beta
1.74
Dividend yield
0.00%
Revenue / share
$4.59
50-day avg
$7.12
200-day avg
$6.61
52-week high
$21.34
52-week low
$2.62
CEO
Henry H. Ji

ETFs linked to SCLX

Broad-market and Healthcare sector ETFs an investor holding Scilex Holding is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how SCLX fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze SCLX in PortView →

Similar companies

Frequently asked questions

What is the ticker symbol for Scilex Holding?
Scilex Holding trades under the ticker SCLX on NASDAQ.
Which exchange is SCLX listed on?
SCLX is listed on NASDAQ.
What sector does Scilex Holding operate in?
Scilex Holding is classified in the Healthcare sector (Drug Manufacturers - General industry).
How can PortView help analyze SCLX in a portfolio?
PortView shows SCLX's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.